CIK: 1242110 - Address: C/O Aligos Therapeutics, Inc., 1 Corporate Drive, 2Nd Floor, South San Francisco, CA 94080
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11616-1259-213
S%wins17676733508353

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/21/08 19:02
5/19/08
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAHFrmr ChiM.d18710.117197D9-40-87-16-2201-2429-19-21
5/21/08 19:02
5/19/08
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAHFrmr ChiS.d-28515.377-19-727D9-40-87-16-2201-2429-19-21
1/16/08 20:41
1/16/08
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAOChief ScS-9017.9118-5-891D-4-44-28-619294051-2-21-9-17-56
1/3/08 20:00
1/2/08
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAOChief ScS-4513.267-3-1000D-20-57-50-29-20-11-7-143935441-17
10/23/07 19:00
10/22/07
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAOChief ScS-9719.4411-5-891D22-12-36-17-42-2-3-20-19-6-15-32
11/2/06 17:30
10/31/06
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAOChief ScM.d20210.1119200D756247403030-5-210-26326-11
11/2/06 17:30
10/31/06
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAOChief ScS.d-44021.9819-20-1000D756247403030-5-210-26326-11
8/28/06 16:18
8/14/06
ITMNIntermune IncDEHealthDrugPharmaceutical PreparationsBlatt LawrenceCAOChief ScS-5916.456-4-1718D585-138994211-1287910

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact